PMID- 32705163 OWN - NLM STAT- MEDLINE DCOM- 20210601 LR - 20210601 IS - 1791-244X (Electronic) IS - 1107-3756 (Print) IS - 1107-3756 (Linking) VI - 46 IP - 3 DP - 2020 Sep TI - Activation of SIRT1 promotes cartilage differentiation and reduces apoptosis of nucleus pulposus mesenchymal stem cells via the MCP1/CCR2 axis in subjects with intervertebral disc degeneration. PG - 1074-1084 LID - 10.3892/ijmm.2020.4668 [doi] AB - Intervertebral disc degeneration (IDD) is a condition involving disruption of the bone tissue distribution. Nucleus pulposus mesenchymal stem cells (NPMSCs) and Sirtuin 1 (SIRT1) play important roles in bone diseases, therefore the aim of the present study was to evaluate the roles of SIRT1 and NPMSCs in IDD. First, NPMSCs were harvested from patients with IDD. Then, the NPMSCs were treated with a SIRT activator, and monocyte chemoattractant protein 1 (MCP1) and chemokine receptor 2 (CCR2) inhibitors. Indices related to NPMSC growth, proliferation, differentiation and apoptosis were measured. Subsequently, IDD rat models were established and were transfected with NPMSCs overexpressing SIRT1. NPMSC apoptosis and cartilage differentiation were detected in the rat IDD model. SIRT1 expression was found to be decreased, and the expression of MCP1 and CCR2 increased in NPMSCs of patients with IDD. The upregulation of SIRT1 and the downregulation of the MCP1/CCR2 axis promoted cartilage differentiation and reduced the number of apoptotic NPMSCs. Furthermore, MCP1 reversed the progression of the cartilage differentiation of NPMSCs and the inhibition of NPMSC apoptosis induced by SIRT1 overexpression. Moreover, the transplantation of rat NPMSCs overexpressing SIRT1 relieved IDD in rats. Therefore, SIRT1 overexpression improved cartilage differentiation and reduced the apoptosis of NPMSCs by inactivating the MCP1/CCR2 axis, thus attenuating IDD in rats. FAU - Ou, Xuancheng AU - Ou X AD - The Second School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong 510515, P.R. China. FAU - Ying, Jinwei AU - Ying J AD - Department of Orthopedic Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325000, P.R. China. FAU - Bai, Xuedong AU - Bai X AD - Department of Orthopedic Surgery, The Sixth Medical Centre of PLA General Hospital, Beijing 100048, P.R. China. FAU - Wang, Chaofeng AU - Wang C AD - Department of Orthopedic Surgery, The Sixth Medical Centre of PLA General Hospital, Beijing 100048, P.R. China. FAU - Ruan, Dike AU - Ruan D AD - The Second School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong 510515, P.R. China. LA - eng PT - Journal Article DEP - 20200703 PL - Greece TA - Int J Mol Med JT - International journal of molecular medicine JID - 9810955 RN - 0 (CCL2 protein, human) RN - 0 (CCR2 protein, human) RN - 0 (Chemokine CCL2) RN - 0 (Receptors, CCR2) RN - EC 3.5.1.- (SIRT1 protein, human) RN - EC 3.5.1.- (Sirtuin 1) SB - IM MH - Aged MH - Animals MH - Apoptosis MH - Cartilage/metabolism/pathology MH - Cell Differentiation MH - Cells, Cultured MH - Chemokine CCL2/*metabolism MH - Chondrogenesis MH - Female MH - Humans MH - Intervertebral Disc Degeneration/genetics/*metabolism/pathology MH - Male MH - Mesenchymal Stem Cells/cytology/metabolism/pathology MH - Middle Aged MH - Nucleus Pulposus/cytology/metabolism/pathology MH - Rats, Sprague-Dawley MH - Receptors, CCR2/*metabolism MH - *Signal Transduction MH - Sirtuin 1/genetics/*metabolism MH - Up-Regulation PMC - PMC7387093 EDAT- 2020/07/25 06:00 MHDA- 2021/06/02 06:00 PMCR- 2020/07/03 CRDT- 2020/07/25 06:00 PHST- 2020/01/17 00:00 [received] PHST- 2020/05/07 00:00 [accepted] PHST- 2020/07/25 06:00 [entrez] PHST- 2020/07/25 06:00 [pubmed] PHST- 2021/06/02 06:00 [medline] PHST- 2020/07/03 00:00 [pmc-release] AID - ijmm-46-03-1074 [pii] AID - 10.3892/ijmm.2020.4668 [doi] PST - ppublish SO - Int J Mol Med. 2020 Sep;46(3):1074-1084. doi: 10.3892/ijmm.2020.4668. Epub 2020 Jul 3.